CO5180555A1 - Nuevos compuestos derivados de ureido piperidina, antagonistas selectivos de los receptores nk, humanos, procedimiento para su obtencion y composiciones farmaceuti- cas que los contienen - Google Patents

Nuevos compuestos derivados de ureido piperidina, antagonistas selectivos de los receptores nk, humanos, procedimiento para su obtencion y composiciones farmaceuti- cas que los contienen

Info

Publication number
CO5180555A1
CO5180555A1 CO99064055A CO99064055A CO5180555A1 CO 5180555 A1 CO5180555 A1 CO 5180555A1 CO 99064055 A CO99064055 A CO 99064055A CO 99064055 A CO99064055 A CO 99064055A CO 5180555 A1 CO5180555 A1 CO 5180555A1
Authority
CO
Colombia
Prior art keywords
pharmaceutical compositions
compositions containing
piperidina
ureido
receptors
Prior art date
Application number
CO99064055A
Other languages
English (en)
Inventor
Alain Aulombard
Xavier Edmonds-Alt
Vicenzo Prosetto
Broeck Didier Van
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of CO5180555A1 publication Critical patent/CO5180555A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a los compuestos de fórmula (I):<EMI FILE="99064055_1" ID="1" IMF=JPEG >en el cual:- R1 y R2 representan cada uno independientemente uno del otro hidrógeno o un alquilo (C1-C3);- o R1 y R2 conjuntamente con el átomo de nitrógeno al cual están unidos constituyen un radical heterocíclico elegido entre: un pirrolidin-1-ilo, un piperidin,-1-ilo, un morfolin-4-ilo.- O R1 representa un metilo y R2 representa un metoxi;- R3 representa hidrógeno o un alquilo (C1-C3);en formas racémicas u ópticamente puras, sus procedimientos de obtención y las composiciones farmacéuticas que los contienen.Estos compuestos son antagonistas selectivos del selector NK3.
CO99064055A 1998-10-09 1999-10-08 Nuevos compuestos derivados de ureido piperidina, antagonistas selectivos de los receptores nk, humanos, procedimiento para su obtencion y composiciones farmaceuti- cas que los contienen CO5180555A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9812859A FR2784377B3 (fr) 1998-10-09 1998-10-09 Nouveaux composes derives d'ureidopiperidine, antagonistes selectifs des recepteurs nk3 humains, procede pour leur obtention et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
CO5180555A1 true CO5180555A1 (es) 2002-07-30

Family

ID=9531536

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99064055A CO5180555A1 (es) 1998-10-09 1999-10-08 Nuevos compuestos derivados de ureido piperidina, antagonistas selectivos de los receptores nk, humanos, procedimiento para su obtencion y composiciones farmaceuti- cas que los contienen

Country Status (25)

Country Link
US (1) US6465489B1 (es)
EP (1) EP1119552A1 (es)
JP (1) JP2002527423A (es)
KR (1) KR20010085903A (es)
CN (1) CN1133622C (es)
AR (1) AR029148A1 (es)
AU (1) AU751592B2 (es)
BR (1) BR9914397A (es)
CA (1) CA2346729A1 (es)
CO (1) CO5180555A1 (es)
DZ (1) DZ2905A1 (es)
EA (1) EA003613B1 (es)
EE (1) EE200100214A (es)
FR (1) FR2784377B3 (es)
HU (1) HUP0201709A3 (es)
IL (1) IL142362A0 (es)
IS (1) IS5897A (es)
NO (1) NO20011779L (es)
NZ (1) NZ510779A (es)
PL (1) PL347910A1 (es)
SK (1) SK4642001A3 (es)
TR (1) TR200101030T2 (es)
TW (1) TW539669B (es)
WO (1) WO2000021931A1 (es)
YU (1) YU26001A (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068604A2 (en) 2000-03-14 2001-09-20 Sepracor, Inc. 3-substituted piperidines comprising urea functionality, and methods of use thereof
US20060128752A1 (en) * 2002-07-03 2006-06-15 Giuseppe Alvaro Chemical compounds
US20110144081A1 (en) * 2009-12-15 2011-06-16 Henner Knust Pyrrolidine derivatives
US9554659B2 (en) 2012-10-22 2017-01-31 Uwm Research Foundation, Inc. Infant sleep pod
EP3881843A4 (en) * 2018-11-15 2022-08-03 Kyushu University, National University Corporation PROPHYLACTIC OR THERAPEUTIC AGENT AND MEDICAL COMPOSITION FOR IL-31 MEDIATED DISEASE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL99320A (en) 1990-09-05 1995-07-31 Sanofi Sa Arylalkylamines, their preparation and pharmaceutical preparations containing them
FR2676055B1 (fr) 1991-05-03 1993-09-03 Sanofi Elf Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2688219B1 (fr) * 1992-03-03 1994-07-08 Sanofi Elf Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
FR2719311B1 (fr) 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
FR2738819B1 (fr) 1995-09-14 1997-12-05 Sanofi Sa Nouveaux composes antagonistes selectifs du recepteur nk3 humain, procede pour leur obtention et compositions pharmaceutiques les contenant
AU4176997A (en) 1996-09-16 1998-04-02 Warner-Lambert Company 3-alkyl-3-phenyl-piperidines

Also Published As

Publication number Publication date
NZ510779A (en) 2003-07-25
TW539669B (en) 2003-07-01
TR200101030T2 (tr) 2001-08-21
IS5897A (is) 2001-03-16
EE200100214A (et) 2002-08-15
EA200100299A1 (ru) 2001-10-22
SK4642001A3 (en) 2001-09-11
NO20011779D0 (no) 2001-04-06
DZ2905A1 (fr) 2004-03-01
JP2002527423A (ja) 2002-08-27
CN1133622C (zh) 2004-01-07
IL142362A0 (en) 2002-03-10
AU751592B2 (en) 2002-08-22
KR20010085903A (ko) 2001-09-07
AU5988799A (en) 2000-05-01
AR029148A1 (es) 2003-06-18
FR2784377B3 (fr) 2000-11-17
EP1119552A1 (fr) 2001-08-01
CA2346729A1 (en) 2000-04-20
NO20011779L (no) 2001-06-07
US6465489B1 (en) 2002-10-15
YU26001A (sh) 2003-04-30
HUP0201709A2 (en) 2002-09-28
EA003613B1 (ru) 2003-06-26
BR9914397A (pt) 2001-06-26
CN1329594A (zh) 2002-01-02
FR2784377A1 (fr) 2000-04-14
PL347910A1 (en) 2002-04-22
HUP0201709A3 (en) 2003-03-28
WO2000021931A1 (fr) 2000-04-20

Similar Documents

Publication Publication Date Title
GT199900119A (es) Jarabe antihistaminico estabilizado.
ES2033049T3 (es) Procedimiento para preparar derivados de oxa- o tia-zolina.
PE20050896A1 (es) Intermediarios de quinolina como inhibidores de tirosina quinasas de receptores y la sintesis de los mismos
AR065795A1 (es) Derivados de aza-piridopirimidinona,metodo de preparacion,medicamentos que los contienen y usos como agentes antitromboticos, antihiperlipidemicos y antidiabeticos,entre otros.
ES2161231T3 (es) Compuestos heterociclicos como antagonistas de bradiquinina.
AR052312A1 (es) 2- anilinopirimidinas sustituidas como inhibidores de la quinasa del ciclo celular o del receptor de la tirosina quinasa, su preparacion y medicamentos preparados en base al compuesto
AR043087A1 (es) Compuestos de pirrolotriazinas, utiles como inhibidores de cinasas y las composiciones farmaceuticas que los contienen
AR006545A1 (es) Compuestos sustitutos de las catecolaminas, utiles como antagonistas beta3, composiciones farmaceuticas que los contienen y compuestos intermediarios deaplicacion exclusiva en la preparacion de dichos compuestos
CO5130017A1 (es) Derivados de quinolin-2-ona alquinil sustituidos utiles como agentes anticancerosos
ES2036551T3 (es) Compuestos heterociclicos.
UY27427A1 (es) Nuevas dihidro-pteridinonas, procedimientos para su preparación y su utilización como medicamentos
CY1108963T1 (el) Λιπαρα οξεα μεσης-αλυσου, γλυκεριδια και αναλογα ως διεγερτες ερυθροποιησης
ES2147840T3 (es) Antagonistas de receptores de taquiquininas con morfolina.
PA8601201A1 (es) Ligandos del receptor cannabinoide y usos de los mismos
AR048567A1 (es) Derivados de benzoxazinona, su preparacion y composiciones farmaceuticas.
AR007969A1 (es) Compuestos derivados de pirroles sustituidos, su utilizacion y composiciones farmaceuticas que contienen tales compuestos
ES2059416T3 (es) 1,4-dihidropiridina-enantiomeros.
AR005672A1 (es) Derivados de la distamicina, proceso para prepararlos, y su utilizacion como agentes antitumorales y antivirales.
PE14696A1 (es) Derivado de fenetanolamina
CO5210890A1 (es) Compuestos quimicos del tipo benzodia - o tiazoles y su proceso de obtencion
CO5180555A1 (es) Nuevos compuestos derivados de ureido piperidina, antagonistas selectivos de los receptores nk, humanos, procedimiento para su obtencion y composiciones farmaceuti- cas que los contienen
ES2045044T3 (es) Derivados de sulfonamidolfenilo y agentes terapeuticos y preventivos de la arritmia que contienen los mismos.
ES2061513T3 (es) Compuestos quimicos.
PE20021018A1 (es) DERIVADOS DE ß - CARBOLINA
MX9304424A (es) Bencimidazoles, medicamentos que contienen estos compuestos y procedimiento para su preparacion.

Legal Events

Date Code Title Description
FC Application refused